Stockscreener 앱 받기
10.18
2.52%
0.25
시간 외 거래:
10.41
0.23
+2.26%
전일 마감가:
$9.93
열려 있는:
$9.8
하루 거래량:
65,875
Relative Volume:
0.53
시가총액:
$N/A
수익:
-
순이익/손실:
-
주가수익비율:
-
EPS:
-
순현금흐름:
-
1주 성능:
+0.10%
1개월 성능:
-20.16%
6개월 성능:
+36.83%
1년 성능:
+39.84%
1일 변동 폭
$9.7101
$10.48
1주일 범위
$9.7101
$10.71
52주 변동 폭
$3.62
$13.67
Direxion Daily Pharmaceutical Medical Bull 3 X Etf Stock (PILL) Company Profile
명칭
Direxion Daily Pharmaceutical Medical Bull 3 X Etf
전화
-
주소
-
Compare PILL vs VTI, SPY, IVV, VB, QQQ
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
PILL
Direxion Daily Pharmaceutical Medical Bull 3 X Etf
|
10.18 | 0 | 0 | 0 | 0 | 0.00 |
|
VTI
Vanguard Total Stock Market Etf
|
325.44 | 417.53B | 0 | 0 | 0 | 0.00 |
|
SPY
State Street Spdr S P 500 Etf Trust
|
659.80 | 372.57B | 0 | 0 | 0 | 0.00 |
|
IVV
Ishares Core S P 500 Etf
|
660.93 | 253.41B | 0 | 0 | 0 | 0.00 |
|
VB
Vanguard Small Cap Etf
|
263.35 | 160.59B | 0 | 0 | 0 | 0.00 |
|
QQQ
Invesco Qqq Trust Series 1
|
593.02 | 124.43B | 0 | 0 | 0 | 0.00 |
Direxion Daily Pharmaceutical Medical Bull 3 X Etf 주식(PILL)의 최신 뉴스
Sickle Cell Disease Market: Investment-Ready Growth Trends to 2034 – DelveInsight | BRL Medicine, Oryzon Genomics, GlaxoSmithKline, Agios Pharma, Beam Therapeutics Inc., Graphite Bio, Roche, Quercis - Barchart
Dermatomyositis Market: Strong Pharma Growth Forecast Through 2034 – DelveInsight | Octapharma, Argenx, AstraZeneca, Bristol-Myers Squibb Company, Pfizer Inc., Octapharma AG, Corbus Pharma, Holdings - Barchart.com
Chronic Myeloid Leukemia Clinical Trial Pipeline Appears Robust With 20+ Key Pharma Companies Actively Working in the Domain | DelveInsight | Kartos Therapeutics, AOP Orphan Pharmaceuticals - Barchart
Dr. Ranjan Rajbanshi Scholarship for Medical Students Announces National Essay Competition for Aspiring Healthcare Professionals - Barchart.com
(PILL) Movement Within Algorithmic Entry Frameworks - Stock Traders Daily
Pharmaceutical Drug Delivery Market Projected to Reach $2,546.0 Billion by 2029 with Advancements in Targeted Therapies - Barchart.com
Vanda Announces FDA Grants Landmark Hearing for HETLIOZ® in Jet Lag Disorder, the First Drug Approval Hearing in Over 40 Years - Barchart.com
Paroxysmal Nocturnal Hemoglobinuria Market: Expanding Revenue Landscape to 2034 – DelveInsight | Alexion Pharma, Hoffmann-La Roche, Novartis, Regeneron Pharma, AKARI Therapeutics, AstraZeneca - Barchart.com
Multiple Myeloma Clinical Trial Pipeline Expands as 75+ Companies Driving Innovation in the Therapeutics | DelveInsight - Barchart
RARE SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Reminds Ultragenyx Pharmaceutical (RARE) Investors of Securities Class Action Deadline on April 6, 2026 - Barchart.com
How (PILL) Movements Inform Risk Allocation Models - Stock Traders Daily
Hypertension Treatment Pipeline Shows Strong Momentum as 80+ Pharma Companies in the Race | DelveInsight - Barchart.com
Student-Led Nonprofit Empathy in Medicine Initiative Launches National Chapter for High School and College Students - Barchart.com
North America Biomarkers Market to Reach $42.25 Billion by 2030, Driven by Precision Medicine and Safety Biomarker Adoption - Barchart.com
Cosmos Health Highlights Approximately $15 Million Fair Market Value of Real Estate Assets, Exceeding Current Market Capitalization; Evaluates Monetization Options to Address Significant Discount to Book Value - Barchart.com
XLRE Trails the S&P 500 by 5% Despite Lower Interest Rates That Were Supposed To Help - AOL.com
Trading Systems Reacting to (PILL) Volatility - Stock Traders Daily
6 Best Defense ETFs to Watch in 2026 - The Motley Fool
5 Small-cap Biotech ETFs to Watch - Investing News Network
How Direxion Daily Pharmaceutical & Medical Bull 3x Shares (PILL) Affects Rotational Strategy Timing - Stock Traders Daily
CURE: Benefits And Caveats Of The Leveraged Healthcare ETF (NYSEARCA:CURE) - Seeking Alpha
Short Interest in Direxion Daily Pharmaceutical & Medical Bull 3X Shares (NYSEARCA:PILL) Drops By 37.4% - Defense World
ENN Energy (OTCMKTS:XNGSF) Trading Down 1.6% – Here’s Why - Defense World
Fibromyalgia Market: Expanding Revenue Landscape to 2034 – DelveInsight | UCB Pharma, Eli Lilly and Company, Merck, Aptinyx, Astellas Pharma, Tonix Pharma, UCB Biopharma SRL, GSK, UCB Pharma - Barchart
(PILL) and the Role of Price-Sensitive Allocations - Stock Traders Daily
What You Need To Know Ahead of Baxter International's Earnings Release - Barchart
Is Apellis Pharmaceuticals’ FDA Win Just the Beginning? - AOL.com
Why Vera Therapeutics Stock Zoomed Higher Today - AOL.com
Trump Unveils 'Great Healthcare Plan,' Takes Aim At PBM 'Kickbacks' - Benzinga
GE HealthCare’s Q4 2025 Earnings: What to Expect - Barchart.com
Responsive Playbooks and the PILL Inflection - Stock Traders Daily
Celltrion presents innovative drug pipeline and U.S. manufacturing and R&D expansion strategy at the 44th Annual J.P. Morgan Healthcare Conference - Barchart.com
Gamble on Huge Gains with These 3 Best Biotech Stocks to Buy for 2026 - Barchart.com
What Investors Should Know About a $163K AnaptysBio Insider Sale - AOL.com
Clarity Wealth Advisors LLC Reduces Holdings in iShares Global Healthcare ETF $IXJ - Defense World
Q4 Earnings: Beat, Miss, or Market Whiplash? - Direxion
Ignore Nektar Therapeutics Stock in 2026 and Load Up on This One Instead - AOL.com
Understanding the Setup: (PILL) and Scalable Risk - Stock Traders Daily
U.S. Equity ETF Tracker | Storage price hikes spread, Micron hits new highs; 2x Long MU ETF rises over 7% - news.futunn.com
U.S. Stock ETF Tracker | Storage price hikes spread, Micron hits new highs, 2x Long MU ETF rises over 7% - 富途牛牛
Cathie Wood Is Doubling Down on Recursion Pharmaceuticals Stock. Should You Buy RXRX Here? - Barchart.com
Direxion Daily Pharmaceutical & Medical Bull 3X Shares declares quarterly distribution of $0.0327 - MSN
Why (PILL) Price Action Is Critical for Tactical Trading - Stock Traders Daily
Trump, nine pharmaceutical companies strike deal to cut prices - Yahoo! Finance Canada
Biotech Bull ETF Surges To 20-Month High: Analysts Say Medicare’s Drug-Pricing Blow Is Softer Than Feared - MSN
Top Performing Leveraged/Inverse ETFs: 12/14/2025 - ETF Database
CURE: The Leveraged ETF That Turbocharges The Leading U.S. Healthcare Stocks (CURE) - Seeking Alpha
Understanding Momentum Shifts in (PILL) - Stock Traders Daily
Form N-CSR UPRIGHT INVESTMENTS TRUS For: Sep 30 - StreetInsider
Improving Economic Signals Drives Participation In Direxion's Daily Retail Bull 3X Shares RETL ETF - inkl
Healthcare Relevancies Clashes With Premium Valuations For Direxion's LLY-Focused ELIL, ELIS ETFs - inkl
Direxion Daily Pharmaceutical Medical Bull 3 X Etf (PILL) 재무 분석
Direxion Daily Pharmaceutical Medical Bull 3 X Etf (PILL)에 대한 금융 데이터가 없습니다. 더 많은 정보를 위해 다른 주식을 확인해보세요.
매출
순이익
현금흐름
주당 순 이익
0.14%
0.24%
자본화:
|
볼륨(24시간):